Skip to main content
Quest Diagnostics

Analyzing the Mitochondrial Genome of Over 2500 Patients With Retinal Disease

ARVO 2021: Revolutionary Eye and Vision Research
Virtual [in-person conference canceled], May 1 - 6, 2021

Analyzing the Mitochondrial Genome of Over 2500 Patients With Retinal Disease
Authors: von Nandelstadh P, Tuupanen S, Gandia M, Vattulainen-Collanus S, Kämpjärvi K, Känsäkoski J, Merkkiniemi K, Sarantaus L, Västinsalo H, Perez-Carro R, Tallila J, Isokallio M, Kytölä V, Muona M, Sistonen J, Saarinen I, Koskenvuo J, Alastalo T-P

Specialties: Genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.